MedPath

Standard PET/CT vs. Digital PET/CT

Not Applicable
Completed
Conditions
Cancer
Interventions
Diagnostic Test: Digital PET/CT scan
Registration Number
NCT03081767
Lead Sponsor
Stanford University
Brief Summary

The investigators wish to determine if standard and digital PET/CT scanners provide equivalent results for disease detection and diagnosis.

Detailed Description

There will be a single injection of the PET radiopharmaceutical followed by a standard PET/CT scan and immediately after by the digital PET/CT scan, or vice versa. The investigators wish to determine if image quality is equivalent with the digital PET/CT scanner.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
199
Inclusion Criteria
  • Patient is ≥ 18 years old at the time of the scan
  • Patient provides written informed consent
  • Patient is referred for standard (F18 FDG; F18 NaF; Ga68 DOTATATE) or research (68Ga PSMA or 68Ga RM2) PET/CT
  • Patient is capable of complying with study procedures
  • Patient is able to remain still for duration of imaging procedure (approximately 60 minutes total for both PET/CT)
Exclusion Criteria
  • Patient is pregnant or nursing

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Patients undergoing digital PET/CTDigital PET/CT scanSingle arm prospective study of paired imaging studies. Patients who are referred to Nuclear Medicine and are scheduled to undergo imaging on the standard PET/CT will also have imaging performed on the digital PET/CT.
Primary Outcome Measures
NameTimeMethod
Diagnostic Image Qualityan expected average of 3 hours

Diagnostic image quality will be determined using a 5-point Likert Scale that reads:

5 - Diagnostic: Excellent diagnostic image quality;

4 - Diagnostic: Good diagnostic image quality;

3 - Diagnostic: Acceptable diagnostic image quality;

2 - Sub-optimal diagnostic: image quality with limited additional clinical information;

1 - Non-diagnostic: non-diagnostic image quality

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Stanford University

🇺🇸

Stanford, California, United States

© Copyright 2025. All Rights Reserved by MedPath